期刊
JOURNAL OF TRANSLATIONAL MEDICINE
卷 14, 期 -, 页码 -出版社
BMC
DOI: 10.1186/s12967-016-1019-1
关键词
Proteomics; Biomarkers; 2D-DIGE; SELDI; Nonunion; Innate immunity; Hepcidin; Complement; Apolipoprotein; S100A8
资金
- Region Wallonne
- Fond d' Investissement pour la Recherche Scientifique (FIRS), CHU Liege, Belgium
Background: Nonunion is a failure of healing following a bone fracture. Its physiopathology remains partially unclear and the discovery of new mediators could promote the understanding of bone healing. Methods: Thirty-three atrophic nonunion (NU) patients that failed to demonstrate any radiographic improvement for 6 consecutive months were recruited for providing serum samples. Thirty-five healthy volunteers (HV) served as the control group. Proteomics studies were performed using SELDI-TOF-MS and 2D-DIGE approaches, associated or not with Proteominer (R) preprocessing, to highlight biomarkers specific to atrophic nonunion pathology. Peak intensities were analyzed by two statistical approaches, a nonparametric Mann-Whitney U tests (univariate approach) and a machine-learning algorithm called extra-trees (multivariate approach). Validation of highlighted biomarkers was performed by alternative approaches such as microfluidic LC-MS/MS, nephelometry, western blotting or ELISA assays. Results: From the 35 HV and 33 NU crude serum samples and Proteominer (R) eluates, 136 spectra were collected by SELDI-TOF-MS using CM10 and IMAC-Cu2+ ProteinChip arrays, and 665 peaks were integrated for extra-trees multivariate analysis. Accordingly, seven biomarkers and several variants were identified as potential NU biomarkers. Their levels of expression were found to be down-or up-regulated in serum of HV vs NU. These biomarkers are inter-atrypsin inhibitor H4, hepcidin, S100A8, S100A9, glycated hemoglobin beta subunit, PACAP related peptide, complement C3 alpha-chain. 2D-DIGE experiment allowed to detect 14 biomarkers as being down-or up-regulated in serum of HV vs NU including a cleaved fragment of apolipoprotein A-IV, apolipoprotein E, complement C3 and C6. Several biomarkers such as hepcidin, complement C6, S100A9, apolipoprotein E, complement C3 and C4 were confirmed by an alternative approach as being up-regulated in serum of NU patients compared to HV controls. Conclusion: Two proteomics approaches were used to identify new biomarkers up-or down-regulated in the nonunion pathology, which are involved in bone turn-over, inflammation, innate immunity, glycation and lipid metabolisms. High expression of hepcidin or S100A8/S100A9 by myeloid cells and the presence of advanced glycation end products and complement factors could be the result of a longstanding inflammatory process. Blocking macrophage activation and/or TLR4 receptor could accelerate healing of fractured bone in at-risk patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据